| 标题 |
 Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet 作者：Lorcan McGarvey; Surinder S. Birring; Alyn H. Morice; Peter V. Dicpinigaitis; Ian Pavord; et al 出版日期：2022-03-01 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
秋风
Kao
GingerF
Nole
cdercder
Criminology34
Ali
水煮电吹风
无极微光
罗Eason
OK
null
DW
v0id
渡人舟
唠叨的大门
anugraphics
七听
Freya1528
今夕何夕
皖公网安备34019202002308
